Vol. 30 No. 4 (2017)

Published November 13, 2024
Current Issues of Pharmacy and Medical Sciences

Artykuły

Jerzy Mielko, Karol Rawicz-Pruszynski, Tomasz Jastrzebski, Wojciech Polkowski (Author)
171 - 172
Advances in surgery for peritoneal surface malignancies
PDF
DOI: https://doi.org/10.1515/cipms-2017-0031
Wojciech Polkowski, Karol Rawicz-Pruszynski, Jerzy Mielko, Katarzyna Geca, Magdalena Skorzewska, Bogumila Cisel (Author)
173 - 179
Treatment of peritoneal metastases from gastric carcinoma
PDF
DOI: https://doi.org/10.1515/cipms-2017-0032
Agnieszka Kolak, Michal Lozinski, Slawomir Mandziuk (Author)
180 - 183
Systemic treatment of Krukenberg tumors
PDF
DOI: https://doi.org/10.1515/cipms-2017-0033
Robert Sitarz, Wojciech Polkowski, Ryszard Maciejewski, G Johan A Offerhaus (Author)
184 - 186
Risk of peritoneal dissemination in stomach cancer
PDF
DOI: https://doi.org/10.1515/cipms-2017-0034
Beate Rau, Eva Pachmayr, Dusan Klos, Peter Thuss-Patience, Andreas Brandl (Author)
187 - 189
Does additional HIPEC help after CRS in peritoneal disseminated gastric cancer?
PDF
DOI: https://doi.org/10.1515/cipms-2017-0035
Roman Yarema (Author)
190 - 194
Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments
PDF
DOI: https://doi.org/10.1515/cipms-2017-0036
Tomasz Olesinski (Author)
195 - 197
Surgical treatment of gastric carcinoma with ovarian metastases
PDF
DOI: https://doi.org/10.1515/cipms-2017-0037
Maria Szymankiewicz, Krzysztof Koper, Konrad Dziobek, Zbigniew Kojs, Lukasz Wicherek (Author)
198 - 202
Microbiological monitoring in patients with advanced ovarian cancer before and after cytoreductive surgery – a preliminary report
PDF
DOI: https://doi.org/10.1515/cipms-2017-0038
Malgorzata Skierucha, Karol Polom, Karol Rawicz-Pruszynski, Jerzy Mielko, Robert Sitarz, Ryszard Maciejewski, Franco Roviello, Wojciech Polkowski (Author)
203 - 206
Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
PDF
DOI: https://doi.org/10.1515/cipms-2017-0039
Sebastian Blaj, Pompiliu Piso (Author)
207 - 210
Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?
PDF
DOI: https://doi.org/10.1515/cipms-2017-0040